MTT

Serial Number 90432097
748

Registration Progress

Application Filed
Dec 30, 2020
Under Examination
May 17, 2022
Approved for Publication
Mar 22, 2022
Published for Opposition
Mar 22, 2022
Registered

Trademark Image

MTT

Basic Information

Serial Number
90432097
Filing Date
December 30, 2020
Published for Opposition
March 22, 2022
Drawing Code
4

Status Summary

Current Status
Active
Status Code
748
Status Date
May 19, 2025
Application
Pending
Classes
042

Rights Holder

ALPHYN BIOLOGICS, INC.

03
Address
3724 Thomas Point Road
Annapolis, MD 21403

Ownership History

Alphyn Biologics, LLC

Original Applicant
16
Annapolis, MD

Alphyn Biologics, LLC

Owner at Publication
16
Annapolis, MD

ALPHYN BIOLOGICS, INC.

New Owner After Publication #1
03
Annapolis, MD

Legal Representation

Attorney
Michael J. Hertz

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

42 events
Date Code Type Description Documents
May 18, 2025 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
May 16, 2025 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
May 15, 2025 IUAF S USE AMENDMENT FILED Loading...
Dec 26, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 26, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Dec 26, 2024 EX5G S SOU EXTENSION 5 GRANTED Loading...
Nov 13, 2024 EXT5 S SOU EXTENSION 5 FILED Loading...
Nov 13, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 1, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 30, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 30, 2024 EX4G S SOU EXTENSION 4 GRANTED Loading...
Apr 30, 2024 EXT4 S SOU EXTENSION 4 FILED Loading...
Nov 18, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 16, 2023 EX3G S SOU EXTENSION 3 GRANTED Loading...
Nov 16, 2023 EXT3 S SOU EXTENSION 3 FILED Loading...
Nov 16, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 1, 2023 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
May 16, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 12, 2023 EX2G S SOU EXTENSION 2 GRANTED Loading...
May 12, 2023 EXT2 S SOU EXTENSION 2 FILED Loading...
May 12, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 19, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 17, 2022 EX1G S SOU EXTENSION 1 GRANTED Loading...
Nov 17, 2022 EXT1 S SOU EXTENSION 1 FILED Loading...
Nov 17, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 18, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jul 18, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jul 18, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
May 17, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 22, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 22, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 2, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 14, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 11, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 10, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jan 10, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 12, 2021 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jul 12, 2021 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 12, 2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 30, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 24, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 2, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Research and development of drugs and medicines for the treatment of infections, lung diseases, and skin diseases; Research and development in the pharmaceutical, life sciences, and biomedicine fields; Scientific research, testing, and analysis in the fields of pharmaceuticals, life science, and biomedicine; Medical and scientific research on lung diseases, skin diseases, infections, and cancer; Pharmaceutical products testing, analysis, research, and development
First Use Anywhere: Aug 21, 2024
First Use in Commerce: Aug 21, 2024

Classification

International Classes
042